Septerna, Inc. (SEPN)

38.79 -0.34 (-0.87%) USD  |  NASDAQ  |  Oct 01, 14:31
More

Septerna EPS Diluted (Quarterly) : -0.2894 for June 30, 2026

EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2023. Start Trial.
Date Value
June 30, 2026 -0.2894
March 31, 2026 -0.193
December 31, 2025 -0.2409
September 30, 2025 0.1792
June 30, 2025 -0.5624
March 31, 2025 -0.4888
Date Value
December 31, 2024 -0.6382
September 30, 2024 -0.4622
June 30, 2024 -0.3703
March 31, 2024 -0.319
December 31, 2023 0.7447
September 30, 2023 -0.2465

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Cocrystal Pharma, Inc. -0.2295
CNBX Pharmaceuticals, Inc. -0.0001
GB Sciences, Inc. --
Arvinas, Inc. 2.578
Fulcrum Therapeutics, Inc. -0.3433

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -13.03M
Revenue (Quarterly) 26.75M
Total Expenses (Quarterly) 39.78M
Enterprise Value 1.437B
Gross Profit Margin (Quarterly) 98.40%
Profit Margin (Quarterly) -48.73%
Earnings Yield -1.40%
Normalized Earnings Yield -1.402